COMPARISON OF WEIGHT GAIN CONTRACEPTION ACCEPTORS
DEPOT INJECTION MEDROKSIPROGESTERONE ACETATE WITH NON HORMONAL CONTRACEPTION ACCEPTORS
E. Setiadi *, D. S. Nurdiati *, M. Hakimi *
* Department of Obstetrics & Gynecology, Dr. Sardjito FK-UGM/RSUP, Yogyakarta
ABSTRACT
Background: The explosion of population increase MMR and IMR, 66% of perinatal mortality is influenced maternal condition. Family planning is an effective way to prevent mortality and morbidity of mothers and children. More than 50% of contraceptive acceptors in Wonosobo choosing injectable contraceptives. injectable contraceptives have side effects, 41% listed the reasons not to continue the injectable contraceptive DMPA is the reason for weight gain
Design: Observational prospective cohort
Place of study: Family planning Polyclinics on RSUD Setjonegoro dan Puskesmas Kalikajar Wonosobo Wonosobo
Results: A total of 132 contraceptive acceptors participate in the study. The proportion of the age group, parity and level of food consumption is not homogeneous p <0.05. There is weight gain in DMPA group contraceptive successive 0.46 kg, 1.04 kg and 1.62 kg at 3 months, 6 months and 9 months p <0.05. AUC wide DMPA group and the non-hormonal group 6.25 ± 5.47 and -0.29 ± 1.41, statistically significant difference (p <0,05). With logistic regression, contraceptive DMPA more influence weight gain compared with non-hormonal contraception after month 6 and month 9 with OR 40.65 (13.21 to 125.12) and OR 197.06 (38.78 – 1001.28)
Conclusions: DMPA injectable contraceptives affect weight gain from 3 months after injection, 6 months and 9 months (p<0.05)
Keywords: DMPA, contraception, weight, non-hormonal